What is important to people living with dementia?: the ‘long-list’ of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventions
Andrew Harding(Lancaster University), Siobhán Reilly(University of Bradford), John Keady(Greater Manchester Mental Health NHS Foundation Trust), Carol Opdebeeck(Manchester Metropolitan University), Caroline Swarbrick(Lancaster University), Faraz Ahmed(Lancaster University), Reena Lasrado(Manchester Academic Health Science Centre), Ingrid Hellström(Linköping University), Paula Williamson(University of Liverpool), David Challis(University of Manchester), Hazel Morbey(Lancaster University), Iracema Leroi(Trinity College Dublin), Alistair Burns(University of Manchester)
Cited by 56
Related Papers
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
|PLoS ONE|2008|1.5k
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228